Updated Audit of Selected Aspects of the Swine Flu Program

HRD-79-47: Published: Feb 6, 1979. Publicly Released: Mar 6, 1979.

Additional Materials:

Contact:

Office of Public Affairs
(202) 512-4800
youngc1@gao.gov

The following aspects of the swine flu program were examined during an updated audit: the amount each vaccine manufacturer received, including profit; the amount the Federal Government paid in procuring vaccine, including the status of agreements with each vaccine manufacturer; the amount the Federal Government paid for insuring the vaccine; the amount the Department of Health, Education, and Welfare (HEW) paid for program administration; and the amount the Federal Government has paid for claims and the number of claims pending. The amount appropriated for the program by Congress was over $135 million. Many of the above cost elements are still unresolved, primarily because: (1) vaccine prices have not been finally negotiated; (2) the Government has not completed processing most of the claims it has received; (3) the Government is still receiving claims for adverse vaccine reactions; and (4) HEW is still incurring costs for research studies of children vaccinated during the program.

HEW incurred overhead and other costs in addition to those charged to the $135 million appropriation. More than 3,000 swine flu-related claims totaling over $3,159.6 million had been filed against the Government by December 1978; however, the Government has paid only 11 of these claims totaling $36,600. The manufacturers of the vaccine have submitted cost claims of about $39.4 million and have been paid about $39.7 million. The Shope vaccine dispute has not been resolved. The Government may recover some liability costs from the vaccine manufacturers, who had obtained a total of $230 million in liability insurance. This insurance was considered a production cost; the Government funded the first $10 million in self-insurance by the manufacturers, as well as the $220 million of liability insurance purchased from insurance companies for an $8.7 million premium.

Nov 16, 2020

Nov 10, 2020

Nov 9, 2020

Nov 6, 2020

Oct 13, 2020

Sep 30, 2020

Sep 9, 2020

Looking for more? Browse all our products here